Ruiz Ojeda, F.J. ; Wang, J. ; Bäcker, T. ; Krueger, M.* ; Zamani, S. ; Rosowski, S. ; Gruber, T. ; Onogi, Y. ; Feuchtinger, A. ; Schulz, T.J.* ; Fässler, R.* ; Müller, T.D. ; García-Cáceres, C. ; Meier, M. ; Blüher, M. ; Ussar, S.
Active integrins regulate white adipose tissue insulin sensitivity and brown fat thermogenesis.
Mol. Metab. 45:101147 (2021)
Objective: Reorganization of the extracellular matrix is a prerequisite for healthy adipose tissue expansion, whereas fibrosis is a key feature of adipose dysfunction and inflammation. However, very little is known about the direct effects of impaired cell–matrix interaction in adipocyte function and insulin sensitivity. The objective of this study was to determine whether integrin activity can regulate insulin sensitivity in adipocytes and thereby systemic metabolism. Methods: We characterized integrin activity in adipose tissue and its consequences on whole-body metabolism using adipose-selective deletion of β1 integrin (Itgb1adipo-cre) and Kindlin-2 (Kind2adipo-cre) in mice. Results: We demonstrate that integrin signaling regulates white adipocyte insulin action and systemic metabolism. Consequently, loss of adipose integrin activity, similar to loss of adipose insulin receptors, results in a lipodystrophy-like phenotype and systemic insulin resistance. However, brown adipose tissue of Kind2adipo-cre and Itgb1adipo-cre mice is chronically hyperactivated and has increased substrate delivery, reduced endothelial basement membrane thickness, and increased endothelial vesicular transport. Conclusions: Thus, we establish integrin-extracellular matrix interactions as key regulators of white and brown adipose tissue function and whole-body metabolism.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Adipose Tissue ; Brown Fat ; Insulin Receptor ; Insulin Resistance ; Integrins ; Kindlin-2 ; Lipodystrophy ; Obesity
Keywords plus
Language
english
Publication Year
2021
Prepublished in Year
HGF-reported in Year
2021
ISSN (print) / ISBN
2212-8778
e-ISSN
2212-8778
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 45,
Issue: ,
Pages: ,
Article Number: 101147
Supplement: ,
Series
Publisher
Elsevier
Publishing Place
Amsterdam
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30201 - Metabolic Health
30204 - Cell Programming and Repair
30505 - New Technologies for Biomedical Discoveries
30205 - Bioengineering and Digital Health
90000 - German Center for Diabetes Research
Research field(s)
Helmholtz Diabetes Center
Genetics and Epidemiology
Pioneer Campus
Enabling and Novel Technologies
PSP Element(s)
G-502296-001
G-502200-001
G-500591-001
G-500500-001
G-510002-001
A-630600-001
G-500390-001
G-501900-224
G-506501-001
Grants
European Research Council ERC
Deutsche Forschungsgemeinschaft
Fundación Alfonso Martín Escudero
Copyright
Erfassungsdatum
2021-03-26